Sanofi to expand plant in Belgium | Chemical & Engineering News
Volume 94 Issue 17 | p. 15 | Concentrates
Issue Date: April 25, 2016

Sanofi to expand plant in Belgium

Department: Business
Keywords: biologics, biopharmaceuticals, enzyme therapy, manufacturing

Sanofi will spend $340 million to expand its biologics production site in Geel, Belgium. The French drug company already makes active ingredients for enzyme replacement therapies there. Additional capacity along with new process and quality control labs will support Sanofi’s monoclonal antibody development pipeline. Sanofi and its Genzyme biologics business have already invested $680 million at the 15-year-old site.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment